PMV Pharmaceuticals's total assets for Q1 2026 were $96.56M, a decrease of -17.16% from the previous quarter. PMVP total liabilities were $8.60M for the fiscal quarter, a -27.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.